scispace - formally typeset
I

I. C. Munro

Publications -  33
Citations -  3513

I. C. Munro is an academic researcher. The author has contributed to research in topics: Flavoring Agents & Context (language use). The author has an hindex of 25, co-authored 33 publications receiving 3234 citations.

Papers
More filters
Journal ArticleDOI

Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans

TL;DR: It was concluded that the use of Roundup herbicide does not result in adverse effects on development, reproduction, or endocrine systems in humans and other mammals, and glyphosate is noncarcinogenic.
Journal ArticleDOI

Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern.

TL;DR: The relationship between chemical structure and toxicity was explored through the compilation of a large reference database consisting of over 600 chemical substances tested for a variety of endpoints resulting in over 2900 no-observed-effect levels (NOELs), supporting the contention that chemical structure defines toxicity.
Journal ArticleDOI

Soy isoflavones: a safety review.

TL;DR: The current literature supports the safety of isoflavones as typically consumed in diets based on soy or containing soy products.
Journal Article

Recent progress in the consideration of flavoring ingredients under the Food Additives Amendment. 15. GRAS substances.

TL;DR: A list of composes aromatiques generalement consideres comme sans danger by un jury d'expert de l'Association des fabricants d'aromes et d'extraits.
Journal ArticleDOI

Aspartame: review of safety.

TL;DR: The safety of aspartame and its metabolic components was established through extensive toxicology studies in laboratory animals, using much greater doses than people could possibly consume as discussed by the authors, and its safety was further confirmed through studies in several human sub-populations, including healthy infants, children, adolescents, and adults, obese individuals, diabetics; lactating women; and individuals heterozygous (PKUH) for the genetic disease phenylketonuria (PKU) who have a decreased ability to metabolize the essential amino acid, phenylalanine.